Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Saved in:
| Title: | Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. |
|---|---|
| Authors: | Anthony DD; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA., Sulkowski MS; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Smeaton LM; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Damjanovska S; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA., Shive CL; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA., Kowal CM; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA., Cohen DE; AbbVie Inc, North Chicago, Illinois, USA., Bhattacharya D; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Alston-Smith BL; Division of AIDS, National Institutes of Health, Bethesda, Maryland, USA., Balagopal A; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wyles DL; University of Colorado School of Medicine, Denver, Colorado, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2020 Sep 14; Vol. 222 (8), pp. 1334-1344. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32406487 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Anthony+DD%22">Anthony DD</searchLink>; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Sulkowski+MS%22">Sulkowski MS</searchLink>; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Smeaton+LM%22">Smeaton LM</searchLink>; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Damjanovska+S%22">Damjanovska S</searchLink>; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Shive+CL%22">Shive CL</searchLink>; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Kowal+CM%22">Kowal CM</searchLink>; Departments of Medicine and Pathology, VA Medical Center and MetroHealth Medical Center, Case Western Reserve University, ACTG Immunology Support Laboratory, Cleveland Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+DE%22">Cohen DE</searchLink>; AbbVie Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+D%22">Bhattacharya D</searchLink>; Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Alston-Smith+BL%22">Alston-Smith BL</searchLink>; Division of AIDS, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Balagopal+A%22">Balagopal A</searchLink>; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wyles+DL%22">Wyles DL</searchLink>; University of Colorado School of Medicine, Denver, Colorado, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2020 Sep 14; Vol. 222 (8), pp. 1334-1344. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32406487 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiaa254 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1334 Titles: – TitleFull: Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Anthony DD – PersonEntity: Name: NameFull: Sulkowski MS – PersonEntity: Name: NameFull: Smeaton LM – PersonEntity: Name: NameFull: Damjanovska S – PersonEntity: Name: NameFull: Shive CL – PersonEntity: Name: NameFull: Kowal CM – PersonEntity: Name: NameFull: Cohen DE – PersonEntity: Name: NameFull: Bhattacharya D – PersonEntity: Name: NameFull: Alston-Smith BL – PersonEntity: Name: NameFull: Balagopal A – PersonEntity: Name: NameFull: Wyles DL IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 09 Text: 2020 Sep 14 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 222 – Type: issue Value: 8 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |
